CBT: a quiet materials player riding the battery boom

The thesis

Cabot (CBT) is a behind‑the‑scenes materials company that sells carbon black and specialty additives used in tires, batteries, and electronics.[1][2] In Q2 fiscal 2026, Cabot booked $904 million in sales and $1.61 per share in adjusted earnings, and reaffirmed its full‑year 2026 earnings target of $6.00–$6.50 per share.[1][2] Management is cutting roughly $22 million of yearly fixed costs by streamlining assets in South America and Europe, while also raising its quarterly dividend by 5% to $0.4725 per share as of May 1, 2026.[1][2][4] Recent global price increases for specialty carbon black products should support margins as new growth projects come online in 2026.[4][5]

Everyone wishes they'd bought Nvidia early. Here's how to spot the next one.

The biggest winners of the last decade had one thing in common. Our data follows those exact moves — and turns them into 10 names to watch right now.

The big names in the AI, Space, Nuclear and Robotics race. The window to get in early is closing fast. Don't wait.

See the top 10 stocks now — free ›

💡 Why this matters

If you believe in more electric cars, better batteries, and smarter devices, companies like Cabot quietly benefit. They don’t make the final products you see; they make the advanced powders and additives that help batteries conduct electricity and tires last longer.[2][4] As demand for EVs, energy storage, and electronics grows, high‑quality materials become more important, and reliable suppliers can gain pricing power.[4][5] Cabot’s combination of real profits, a growing dividend, and exposure to these trends makes it an interesting way to play the “electrified world” without betting on a single car or battery brand.

▲ Catalysts

+ Next earnings update: Cabot’s fiscal Q3 2026 results are expected around early August 2026; market will watch if $6–$6.50 EPS guidance holds.[2][9]
+ Global price hikes for specialty carbon black announced March 12, 2026 should aid margins as contracts reset through 2026.[4]
+ Asset rationalization in South America and Europe targeting about $22 million annual cost savings once fully implemented.[1][2]
+ Dividend increased 5% to $0.4725 per share on May 1, 2026; higher cash returns can attract income‑focused investors.[2][4]
+ EcoVadis platinum ESG rating again in June 2026, putting Cabot in the top 1% for sustainability and potentially appealing to ESG‑focused funds.[2][4][8]

▼ Risks

! Tire and auto demand is cyclical; a slowdown in car production or freight could hit Cabot’s rubber and carbon black sales.[1][5]
! Reinforcement Materials profits fell 29% year‑on‑year in Q2 2026; further weakness here could offset gains in specialty chemicals.[1]
! Cabot is a mid‑cap industrial; big chemical players and Asian carbon black makers could pressure prices and market share.[4][6]
! Cost‑cutting and asset changes in South America and Europe may face execution hiccups or local regulatory challenges.[1][2]

🎯 One thing to take away

Cabot (CBT) is like a “ingredients” supplier for modern industry: its powders and additives help tires, batteries, and electronics perform better.[2][4] The company is profitable, expects $6–$6.50 per share in earnings for fiscal 2026, and just raised its dividend by 5%, which signals confidence.[1][2][4] Management is trimming about $22 million of yearly costs and nudging up prices on specialty products, aiming to protect margins as demand evolves.[1][2][4] On the flip side, some of its business still depends on traditional tire and auto cycles, and competition in industrial chemicals is real.[1][4] If you’re looking for a quieter way to tap into electrification and advanced materials, CBT is a name worth putting on your watchlist and digging into further.

📊 CBT fundamentals

Revenue, net income, EPS & balance sheet — straight from SEC filings.

View →

Data sources & methodology

All figures derive from official, public-domain government filings. Read our methodology for how we collect, process and score this data. See the methodology →

TZ Researched & published by TradesZ Research

Want our premium picks too?

Pro subscribers get our strongest pre-pop ideas + real-time buy-zone alerts.

Thinking about CBT?

Our data likes 10 other stocks even more right now — under-the-radar names we believe have monster upside potential. Get the free list before the crowd catches on.

Show me the 10 stocks — free →

Free · no credit card · unsubscribe in one click

Not investment advice. We share research and analyses for educational purposes. Investing in stocks involves risk, including possible loss of capital. Always do your own research.